Autopsy report · NCT05142540
Detection and Characterization of Anti-SARS-CoV-2 Salivary Antibodies After COVID-19 Booster Vaccines
Cause of deathSlow enrollment
“No more booster vaccinations are being carried out at the site. Further recruitment is therefore not possible.”
Life of this trial
- Ran for about 10 months before it stopped.
- 140 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Medical University of Graz
- Sponsor type
- University, hospital or other
- Conditions
- Anti-SARS-CoV-2 Antibody Response
- Interventions
- blood and saliva samples will be taken
- Participants
- 140
- Sites
- 1
- Countries
- Austria
Trials that died the same way
- Intradermal Administration of a COVID-19 mRNA Vaccine in Elderly
“Recruitment rate dropped because of national COVID-19 vaccination campaign taking place parallel to this study.” - A Feasibility Study of a Transdiagnostic Compassion Focused Therapy (CFT) Group for Older Adults
“COVID-19 restrictions limited recruitment” - ANTERO-5: Gastric Motility in Postoperative Ileus
“Inadequate recruitment due to COVID-19 restrictions.” - Effects of Music Based Intervention (MBI) on Pain Response and Neurodevelopment in Preterm Infants
“Due to Covid constraints on recruitment” - Efficacy of Probaclac in Irritable Bowel Syndrome in Children Aged 8 to 18 Years
“Recruitment impossible”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.